Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if DTIL is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
24 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bullish
Last trade: buy 15 days ago
Red flags: 5
94 filers reported a long position in DTIL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Aberdeen Group plc | $17.5M | 2.2M | Unchanged |
| Bleichroeder LP | $15.9M | 2M | +21.4% |
| Octagon Capital Advisors LP | $10.6M | 1.4M | -39.6% |
| BOOTHBAY FUND MANAGEMENT, LLC | $10.6M | 1.3M | +26.3% |
| BlackRock, Inc. | $9.2M | 1.2M | +487.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.8M | 1.1M | +22.6% |
| Lynx1 Capital Management LP | $7.5M | 950.5K | -3.5% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | $7.4M | 946.7K | -4.9% |
| Empery Asset Management, LP | $6.1M | 776.1K | -60.6% |
| Affinity Asset Advisors, LLC | $5.1M | 646.6K | +8.1% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.